ADMA Biologics ADMA Other intangible assets—net
Other intangible assets—net at other companies
Other financials
Where this comes from
Reported directly by ADMA Biologics in its filing.
Tagged under the XBRL concept us-gaap:IntangibleAssetsNetExcludingGoodwill.
The official record: ADMA Biologics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about ADMA Biologics's other intangible assets—net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ADMA Biologics's other intangible assets—net?
- ADMA Biologics (ADMA) reported other intangible assets—net of $630K in Q1 2026.
- How has ADMA Biologics's other intangible assets—net changed year-over-year?
- ADMA Biologics's other intangible assets—net increased by 39.4% year-over-year, from $452K to $630K.
- What is the long-term trend for ADMA Biologics's other intangible assets—net?
- Over 5 years (2020 to 2025), ADMA Biologics's other intangible assets—net has grown at a -23.7% compound annual growth rate (CAGR), from $2.44M to $632K.
- What does other intangible assets—net mean?
- This represents the net book value of identifiable non-physical assets such as patents, intellectual property, software licenses, and trademarks, excluding goodwill. These assets are vital for companies relying on proprietary technology and R&D. It captures the value of the company's competitive moat derived from its intellectual property portfolio.